Lining the luminal surface of prosthetic vascular grafts with endothelial c
ells (cell seeding) will lower its thrombogenicity. Commonly used macrovasc
ular human adult endothelial cells (HAEC) require in vitro cultivation befo
re large enough numbers are obtained to cover grafts confluently. Fat-deriv
ed microvascular endothelial cells (MVEC) prove to be a good alternative as
they can be harvested in much larger numbers while showing similar antithr
ombotic and fibrinolytic characteristics. An important anticoagulant functi
on of macrovascular endothelial cells is due to the activity of thrombomodu
lin (TM) on their surface. In this study, the presence and functional activ
ity of TM on fat-derived microvascular cells used in cell seeding was inves
tigated. The expression and localization of TM on MVEC was studied using im
munohistochemistry. Functional activity of TM on MVEC was measured by the g
eneration of activated protein C (APC) and was compared to human umbilical
vein endothelial cells (HUVEC). TM activity was studied in MVEC seeded on e
xpanded polytetrafluorethylene (ePTFE) vascular prostheses and compared to
blank prostheses. We found that TM was expressed on the surface of MVEC, bo
th in vivo and vitro. TM-dependent generation of APC differed significantly
between MVEC and HUVEC (3.98 +/- 1.2 vs. 3.0 +/- 0.7 nM, respectively). Af
ter seeding MVEC on vascular prostheses, TM activity did not change. APC ge
neration was significantly higher on MVEC-seeded vascular grafts compared t
o blank grafts (4.0 +/- 0.7 vs. 1.7 +/- 0.5 nM, respectively). We conclude
that TM is present and highly active on cultured MVEC. When seeded on ePTFE
, MVEC retain the possibility to inhibit thrombin coagulant activity and to
activate protein C. Therefore, since MVEC are readily available, the antic
oagulant properties demonstrated here indicate that this cell type is suita
ble for cell seeding of vascular prostheses.